Penserra Capital Management LLC Fusion Pharmaceuticals Inc. Transaction History

Penserra Capital Management LLC

  • $7.9 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$4.17 - $7.78 $4,086 - $7,624
-980 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.83 - $9.41 $117 - $141
15 Added 1.55%
980 $7,000
Q2 2021

Aug 12, 2021
BUY
$7.97 - $10.66 $159 - $213
20 Added 2.12%
965 $7,000
Q1 2021

May 13, 2021
SELL
$9.75 - $13.09 $97 - $130
-10 Reduced 1.05%
945 $10,000
Q4 2020

Feb 12, 2021
BUY
$11.5 - $13.73 $10,982 - $13,112
955 New
955 $11,000

Others Institutions Holding FUSN

# of Institutions
5
Shares Held
93K
Call Options Held
1.4K
Put Options Held
0
View Full List

About Fusion Pharmaceuticals Inc.

FUSN Quotes by TradingView
  • Ticker FUSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,390,500
  • Description
  • Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...
More about FUSN
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email